Latest Breaking News On - Mario deng - Page 1 : comparemela.com

Published: Jun 04, 2021 Transplant physicians to present 40 scientific abstracts, plus two symposia to highlight latest data from multi-center studies on clinical utility of AlloSure SOUTH SAN FRANCISCO, Calif., June 04, 2021 (GLOBE NEWSWIRE) CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today announced its participation in the 2021 American Transplant Congress (ATC), including two symposia and the presentation of 40 scientific abstracts. “We look forward to sharing groundbreaking findings from ADMIRAL and KOAR, both multi-center, prospective studies as we continue to drive innovation in transplantation,” said Reg Seeto, President & CEO of CareDx. “These are the first long-term studies on donor-derived cell-free DNA. They are part of 40 scientific abstracts from more than 30 authors, re

United statesSouth san franciscoSasha kingMario dengSander flormanManikkam suthanthiranTarek alhamadDeborah jo levineJonathan brombergJacfranz guiteauDaniel brennanManreet kanwarEugenec depasqualeGaurav guptaJonathans brombergSam weigt